| Hans-Günter Meyer-Thompson | international
Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic
Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic.
Mattocks KM, Moore DT, Wischik DL, Lazar CM, Rosen MI.
J Subst Abuse Treat. 2022 Mar 25:108777. doi: 10.1016/j.jsat.2022.108777. Epub ahead of print. PMID: 35346533; PMCID: PMC8949846.